Order Article Reprints

Araujo A, Cook LM, Frieling JS, Tan W, Copland JA II, Kohli M, Gupta S, Dhillon J, Pow-Sang J, Lynch CC, et al. Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer. Cancers. 2021; 13(4):677. https://doi.org/10.3390/cancers13040677

Araujo, Arturo, Leah M. Cook, Jeremy S. Frieling, Winston Tan, John A. Copland, II, Manish Kohli, Shilpa Gupta, Jasreman Dhillon, Julio Pow-Sang, Conor C. Lynch, and et al. 2021. "Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer" Cancers 13, no. 4: 677. https://doi.org/10.3390/cancers13040677

Araujo, A., Cook, L. M., Frieling, J. S., Tan, W., Copland, J. A., II, Kohli, M., Gupta, S., Dhillon, J., Pow-Sang, J., Lynch, C. C., & Basanta, D. (2021). Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer. Cancers, 13(4), 677. https://doi.org/10.3390/cancers13040677